Pharmacokinetics/Pharmacodynamics symposium
Executive Summary
FDA Center for Drug Evaluation and Research Director Carl Peck, MD, emphasized the importance of performing pharmacokinetic and pharmacodynamic studies early in the drug development process to participants at an Oct. 12 conference cosponsored by Marion Labs, the National Center for Toxicological Research and the University of Maryland.